Mink therapeutics awarded prestigious niaid grant to advance allo-inkt cell therapy for prevention of gvhd in stem cell transplant patients

Non-dilutive nih funding supports development of mink's allogeneic inkt platform for immune regulation in high-risk hsct settings non-dilutive nih funding supports development of mink's allogeneic inkt platform for immune regulation in high-risk hsct settings

STEM Ratings Summary

STEM Quant Ranking